DaVita Inc (NYSE:DVA)
$ 137.52 -0.42 (-0.3%) Market Cap: 12.06 Bil Enterprise Value: 23.55 Bil PE Ratio: 15.63 PB Ratio: 13.03 GF Score: 83/100

DaVita Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 03:00PM GMT
Release Date Price: $105.23 (+0.82%)
Kevin Mark Fischbeck
BofA Securities, Research Division - MD in Equity Research

Thank you for joining us today. It's my pleasure to be kicking off the conference with DaVita. DaVita is the largest provider of dialysis -- pure-play provider of dialysis.

And with us today, we have Joel Ackerman, who's the CFO. Joel, thanks for being here.

Joel Ackerman
DaVita Inc. - CFO & Treasurer

It's good to be here.

Questions & Answers

Kevin Mark Fischbeck;Joel
BofA Securities, Research Division - MD in Equity Research

So Joel was crazy enough to allow me to jump right into Q&A. If -- and then depending on any questions, by all means, you can ask them, but I'll start it off for sure. I guess when we think about you guys have provided this 3% to 7% OI growth estimate over time. I mean can you just kind of walk us through the building blocks. I mean a lot of things that happen around COVID and costs? And should we still be thinking about the 3% to 7% as the right number over time?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot